Task: Answer the multiple choice question.
Question: Which drug has a -1.954% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: CCCCn1c(SCC(=O)NC2CCS(=O)(=O)C2)nc2cc(S(N)(=O)=O)ccc21
b: CC1=CC(C)(C)N(C(=O)c2ccccc2)c2ccccc21
c: COc1ccc(-c2cn(CCN)c(-c3ccncc3)n2)cc1
d: Cn1cc([N+](=O)[O-])c(C(=O)N/N=C/c2cc3c(cc2Br)OCO3)n1
e: O=C1C2CC=CCC2C(=O)N1Cc1ccccc1
Answer: a. CCCCn1c(SCC(=O)NC2CCS(=O)(=O)C2)nc2cc(S(N)(=O)=O)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCn1c(SCC(=O)NC2CCS(=O)(=O)C2)nc2cc(S(N)(=O)=O)ccc21
CCCCn1c(SCC(=O)NC2CCS(=O)(=O)C2)nc2cc(S(N)(=O)=O)ccc21
2-(1-butyl-5-sulfamoylbenzimidazol-2-yl)sulfanyl-N-(1,1-dioxothiolan-3-yl)acetamide